Mei D A, Nithipatikom K, Lasley R D, Gross G J
Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee 53226, USA.
J Mol Cell Cardiol. 1998 Jun;30(6):1225-36. doi: 10.1006/jmcc.1998.0687.
Previous research has demonstrated that a transient increase in interstitial adenosine and subsequent activation of ATP-sensitive K+ (KATP) channels are involved in triggering ischemic preconditioning (PC), however, the role of adenosine in mediating the cardioprotection of hypoxic PC and that produced by KATP channel openers is less clear. Thus, the aim of the present study was to determine the role of adenosine in mediating the cardioprotective effects of PC produced by 5 min of ischemia, hypoxia, or by a 5-min intracoronary (i.c.) infusion of the KATP channel opener bimakalim (1 microgram/min). A single microdialysis probe was implanted into the midwall of the ischemic area for sampling of interstitial fluid adenosine and its breakdown products during the PC stimulus, prolonged occlusion (60 min) and during the first 30 min of the reperfusion (3 h) period. Ischemic, hypoxic and bimakalim pretreatment significantly reduced infarct size, 5.3 +/- 1.5; 8.9 +/- 2.5; 11.4 +/- 3.2, respectively, as compared to control: 27.3 +/- 6.5. Both ischemic and hypoxic PC produced similar and significant increases (0.56 +/- 0.13 mumol/l to 1.12 +/- 0.12 mumol/l and 1.32 mumol, control, ischemic and hypoxic PC, respectively) in dialysate adenosine concentration which persisted during the brief 10-min reperfusion period following PC. However, i.c. bimakalim resulted in a significant decrease in dialysate adenosine (0.56 +/- 0.13 mumol/l to 0.22 +/- 0.04 mumol/l) which persisted during the 10-min drug-free period. All three PC protocols resulted in similar decreases in dialysate adenosine, inosine and uric acid concentrations throughout the prolonged ischemic period as compared to control animals. In conclusion (1): PC produced by ischemia or hypoxia results in an increase in interstitial adenosine prior to a prolonged occlusion period; (2) the KATP channel agonist, bimakalim, significantly decreased interstitial adenosine prior to a prolonged occlusion period; (3) ischemic PC, hypoxic PC, and bimakalim pretreatment produced a similar reduction in interstitial adenosine and its breakdown products during the prolonged ischemic period. These results suggest that an increase in interstitial adenosine may be necessary for the initiation of the protective effect of ischemic and hypoxic PC but an increase in adenosine is not necessary for the cardioprotective effect of a direct opener of the KATP channel.
先前的研究表明,间质腺苷的短暂增加以及随后ATP敏感性钾离子(KATP)通道的激活参与了缺血预处理(PC)的触发过程,然而,腺苷在介导低氧预处理的心脏保护作用以及KATP通道开放剂所产生的心脏保护作用中的角色尚不清楚。因此,本研究的目的是确定腺苷在介导由5分钟缺血、低氧或通过5分钟冠状动脉内(i.c.)输注KATP通道开放剂苄甲喹啉(1微克/分钟)所产生的预处理的心脏保护作用中的角色。将单个微透析探针植入缺血区域的中层心肌,以在预处理刺激、延长闭塞(60分钟)期间以及再灌注(3小时)的最初30分钟内采集间质液中的腺苷及其分解产物。与对照组(27.3±6.5)相比,缺血、低氧和苄甲喹啉预处理分别显著减小了梗死面积,分别为5.3±1.5、8.9±2.5、11.4±3.2。缺血预处理和低氧预处理均使透析液中腺苷浓度产生相似且显著的升高(对照组、缺血预处理组和低氧预处理组的透析液腺苷浓度分别为0.56±0.13微摩尔/升、1.12±0.12微摩尔/升和1.32微摩尔/升),且在预处理后的短暂10分钟再灌注期内持续存在。然而,冠状动脉内输注苄甲喹啉导致透析液腺苷显著降低(从0.56±0.13微摩尔/升降至0.22±0.04微摩尔/升),并在10分钟无药期内持续存在。与对照动物相比,所有三种预处理方案在整个延长的缺血期内均使透析液中腺苷、肌苷和尿酸浓度产生相似程度的降低。总之:(1)缺血或低氧产生的预处理在延长闭塞期之前会导致间质腺苷增加;(2)KATP通道激动剂苄甲喹啉在延长闭塞期之前显著降低了间质腺苷;(3)缺血预处理、低氧预处理和苄甲喹啉预处理在延长的缺血期内使间质腺苷及其分解产物产生了相似程度的降低。这些结果表明,间质腺苷的增加可能是缺血预处理和低氧预处理产生保护作用所必需的,但腺苷的增加对于KATP通道直接开放剂的心脏保护作用并非必需。